Kevin Chiu

921 total citations
13 papers, 472 citations indexed

About

Kevin Chiu is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Kevin Chiu has authored 13 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Cell Biology. Recurrent topics in Kevin Chiu's work include Endoplasmic Reticulum Stress and Disease (3 papers), RNA Research and Splicing (3 papers) and Knee injuries and reconstruction techniques (2 papers). Kevin Chiu is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (3 papers), RNA Research and Splicing (3 papers) and Knee injuries and reconstruction techniques (2 papers). Kevin Chiu collaborates with scholars based in United States. Kevin Chiu's co-authors include Maurizio Zanetti, Navin R. Mahadevan, Jeffrey J. Rodvold, Homero Sepulveda, Luis Dellamary, T. Seo, Joshua D. Stewart, Maureen Ibanez, Yusuf Yazıcı and V. Deshmukh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kevin Chiu

12 papers receiving 457 citations

Peers

Countries citing papers authored by Kevin Chiu

Since Specialization

Citations

This map shows the geographic impact of Kevin Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Chiu more than expected).

Fields of papers citing papers by Kevin Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Chiu. The network helps show where Kevin Chiu may publish in the future.

Co-authorship network of co-authors of Kevin Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Chiu. A scholar is included among the top collaborators of Kevin Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Chiu. Kevin Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy 2020 ·Journal of Orthopaedic Research® ·V. Deshmukh, T. Seo, (unknown), Maureen Ibanez, (unknown), (unknown), Joshua D. Stewart, Luis Dellamary, Kevin Chiu, (unknown), Charlene F. Barroga, Sarah J. Kennedy, J. Tambiah, John Hood, Yusuf Yazıcı	25
2	Abstract 5691: SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt pathway inhibition in castration-resistant prostate cancer (CRPC) models 2020 ·Cancer Research ·Carine Bossard, Nathalia Cruz, Kevin Chiu, Brian Eastman, Chi Ching Mak, (unknown), (unknown), (unknown), Timothy Phalen, (unknown)	4
3	SM04690, A potential disease-modifying treatment for knee osteoarthritis, functions through inhibition of CLK2 and DYRK1A, novel molecular regulators of Wnt signaling, chondrogenesis, and inflammation 2019 ·Osteoarthritis and Cartilage ·V. Deshmukh, (unknown), Carine Bossard, T. Seo, (unknown), Maureen Ibanez, (unknown), (unknown), Long Do, Steven Cho, (unknown), Kevin Chiu, M. Pedraza, Yusuf Yazıcı	3
4	SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Acute Myeloid Leukemia Models 2019 ·Blood ·Heekyung Chung, (unknown), (unknown), Kevin Chiu, (unknown), (unknown), Betty Y. Tam, (unknown), (unknown), Timothy Phalen, (unknown)	6
5	SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in Mantle Cell Lymphoma Models 2019 ·Blood ·Heekyung Chung, (unknown), (unknown), Kevin Chiu, (unknown), (unknown), Betty Y. Tam, (unknown), (unknown), Timothy Phalen, (unknown)	3
6	SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in Tumor Protein p53 (TP53)-Mutant Acute Myeloid Leukemia Models 2019 ·Blood ·Heekyung Chung, (unknown), (unknown), Kevin Chiu, (unknown), (unknown), Betty Y. Tam, (unknown), (unknown), Timothy Phalen, (unknown)	5
7	OP0072 INHIBITION OF CLK2 AND DYRK1A BY SM04690 AS A NOVEL MOLECULAR REGULATOR OF WNT SIGNALING, CHONDROGENESIS, AND INFLAMMATION, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS 2019 ·Annals of the Rheumatic Diseases ·V. Deshmukh, (unknown), Carine Bossard, T. Seo, (unknown), Maureen Ibanez, (unknown), (unknown), Long Do, (unknown), (unknown), Kevin Chiu, M. Pedraza, Yusuf Yazıcı	1
8	Effects of SM08502, a novel, oral small-molecule inhibitor of Wnt pathway signaling, on gene expression and antitumor activity in colorectal cancer (CRC) models. 2019 ·Journal of Clinical Oncology ·Carine Bossard, Kevin Chiu, Heekyung Chung, (unknown), (unknown), Brian Eastman, Chi Ching Mak, Long Do, (unknown), (unknown), Timothy Phalen, J. Tambiah, (unknown)	3
9	Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells 2017 ·Science Signaling ·Jeffrey J. Rodvold, Kevin Chiu, Nobuhiko Hiramatsu, Julia K. Nussbacher, (unknown), Navin R. Mahadevan, Karl Willert, Jonathan H. Lin, Maurizio Zanetti	82
10	A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee 2017 ·Osteoarthritis and Cartilage ·V. Deshmukh, (unknown), Charlene F. Barroga, Carine Bossard, S. KC, Luis Dellamary, Joshua D. Stewart, Kevin Chiu, Maureen Ibanez, M. Pedraza, T. Seo, Long Do, Steven Cho, (unknown), Betty Y. Tam, J. Tambiah, John Hood, Nancy E. Lane, Yusuf Yazıcı	176
11	Synthesis and delivery of short, noncoding RNA by B lymphocytes 2013 ·Proceedings of the National Academy of Sciences ·Gonzalo Almanza, (unknown), Jeffrey J. Rodvold, Kevin Chiu, Alexandra DeLaney, Johnny Akers, Clark C. Chen, Maurizio Zanetti	27
12	Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming 2012 ·PLoS ONE ·Navin R. Mahadevan, (unknown), Jeffrey J. Rodvold, Kevin Chiu, Homero Sepulveda, Maurizio Zanetti	118
13	Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway 2012 ·Cancer Letters ·(unknown), Navin R. Mahadevan, Kevin Chiu, Alexandra DeLaney, Maurizio Zanetti	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact